The Pharmacy Times® Zoster resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
A new treatment that targets the physical properties of the herpes virus, not just the virus proteins, shows promise.
According to researchers at the Asan Medical Center in Seoul, South Korea, patients who have left their shingles symptoms untreated have an increased risk of dementia.
In a recent study, researchers found that Zoster Vaccine Live, a type of shingles vaccine, may prevent stroke in some older adults.
Although shingles can affect any age group, risks increase with age.
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Vitamin C and Zinc
Vitamin C and zinc are among the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Giant Food has announced that all vaccinations recommended by the ACIP are once again available at its 153 in-store pharmacies across Virginia, Maryland, Delaware, and the District of Columbia.
People have many reasons for wanting to become a pharmacist, ranging from personal encounters with pharmacists and witnessing experiences of friends and family members to stories they have read online about the profession.
In a study, polymerase chain reaction–confirmed second episodes of herpes zoster occurred in 2 of 660 patients receiving a placebo and 1 of 321 patients receiving ZVL.
Two shingles vaccines are licensed and recommended in the United States.
The investigators identified patients with a first-ever diagnosis of zoster who also had a child in the household with a varicella record.
Rates of some vaccinations are low in these patients, but pharmacists can play a key role in adherence.
Immunization needs for patients aged 19 to 64 years and afflicted with chronic conditions are often overlooked, and necessitate more attention and resources. Pharmacies traditionally do not focus on this patient population; instead often choosing to focus primarily on the population 65 years and over. However, engaging with patients in the 19- to 64-year-old group could go a long way in helping to fill the current immunization void in this population.